Cancer Home > What Is Cabazitaxel Used For?
Cabazitaxel is licensed for the treatment of prostate cancer in men age 18 and older. Using this drug for treating other types of cancer or in combination with other types of chemotherapy would be considered an off-label (unapproved) use of cabazitaxel. This prescription medication works by interfering with certain cell structures, which prevents the cancer from growing and multiplying.
An Overview of Uses for CabazitaxelCabazitaxel (Jevtana®) is a prescription medication approved for the treatment of prostate cancer. It is reserved for "refractory" cases of prostate cancer that have not responded adequately to hormone therapy in people who have already tried docetaxel (Taxotere®).
A prostate cancer diagnosis means that cancer cells have formed in the tissues of the prostate. This disease tends to grow slowly compared with most other cancers. Cell changes may begin 10, 20, or 30 years before a tumor gets big enough to cause symptoms. Eventually, cancer cells may spread (metastasize) throughout the body. By the time symptoms appear, the cancer may be more advanced.
Most cases of prostate cancer never pose a problem. There are either no signs or symptoms, or the disease never becomes a serious threat to a man's health. A much smaller percentage of men are actually treated for prostate cancer. Most men with the condition, however, do not die from this disease. The prognosis varies, depending on the stage (see Prostate Cancer Prognosis and Stages of Prostate Cancer).
Prostate cancer treatment may involve:
- Watchful waiting (see Watchful Waiting for Prostate Cancer)
- Surgery (see Prostate Cancer Surgery)
- Radiation therapy (see Radiation Treatment for Prostate Cancer)
- Hormone therapy (see Prostate Cancer Hormone Therapy)
- Chemotherapy (such as cabazitaxel).
In addition, you may have a combination of treatment methods.